It is important to follow your Veterinarian's prescription instructions for your pet.
Dosage and Administration:
The dose of APOQUEL (oclacitinib maleate) tablets is 0.18 to 0.27 mg oclacitinib/lb (0.4 to 0.6 mg oclacitinib/kg) body weight, administered orally, twice daily for up to 14 days, and then administered once daily for maintenance therapy.
APOQUEL may be administered with or without food.
Possible Side Effects:
In most cases, diarrhea, vomiting, anorexia, and lethargy spontaneously resolved with continued dosing.
APOQUEL is not for use in dogs with serious infections.
APOQUEL may increase susceptibility to infection, including demodicosis, and exacerbate neoplastic
conditions (see Adverse Reactions and Animal Safety).
APOQUEL is not for use in breeding dogs, or pregnant or lactating females
The use of APOQUEL has not been evaluated in combination with glucocorticoids, cyclosporine, or other
systemic immunosuppressive agents.
Dogs receiving APOQUEL should be monitored for the development of infections, including demodicosis,
APOQUEL should be stored at controlled room temperature between 20° to 25°C (68° to 77°F) with excursions
between 15° to 40°C (59° to 104°F).
APOQUEL tablets contain 3.6 mg, 5.4 mg, or 16 mg of oclacitinib as oclacitinib maleate per tablet. Each strength tablets are packaged in 20 and 100 count bottles. Each tablet is scored and marked with AQ and either an S, M, or L that correspond to the different tablet strengths on both sides.